Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group--protocol ALL-99.
Brandalise SR, Pinheiro VR, Aguiar SS, Matsuda EI, Otubo R, Yunes JA, Pereira WV, Carvalho EG, Cristofani LM, Souza MS, Lee ML, Dobbin JA, Pombo-de-Oliveira MS, Lopes LF, Melnikoff KN, Brunetto AL, Tone LG, Scrideli CA, Morais VL, Viana MB.
Brandalise SR, et al. Among authors: yunes ja.
J Clin Oncol. 2010 Apr 10;28(11):1911-8. doi: 10.1200/JCO.2009.25.6115. Epub 2010 Mar 8.
J Clin Oncol. 2010.
PMID: 20212252
Clinical Trial.